gantenerumab (97)(59)								8894

Structure	

Ig ?1- heavy chain / Chaine lourde Ig ?1 / Cadena pesada Ig ?1

qvelvesggg lvqpggslrl scaasgftfs syamswvrqa pgkglewvsa	50

inasgtrtyy adsvkgrfti srdnskntly lqmnslraed tavyycargk	100

gnthkpygyv ryfdvwgqgt lvtvssastk gpsvfplaps skstsggtaa	150

lgclvkdyfp epvtvswnsg altsgvhtfp avlqssglys lssvvtvpss	200

slgtqtyicn vnhkpsntkv dkkvepkscd kthtcppcpa pellggpsvf	250

lfppkpkdtl misrtpevtc vvvdvshedp evkfnwyvdg vevhnaktkp	300 

reeqynstyr vvsvltvlhq dwlngkeykc kvsnkalpap iektiskakg	350

qprepqvytl ppsrdeltkn qvsltclvkg fypsdiavew esngqpenny	400

kttppvldsd gsfflysklt vdksrwqqgn vfscsvmhea lhnhytqksl	450

slspgk								456

? light chain / Chaine legere Ig ?- / Cadena ligera Ig ?

divltqspat lslspgerat lscrasqsvs ssylawyqqk pgqaprlliy		50

gassratgvp arfsgsgsgt dftltissle pedfatyycl qiynmpitfg 	100

qgtkveikrt vaapsvfifp psdeqlksgt asvvcllnnf ypreakvqwk 	150

vdnalqsgns qesvteqdsk dstyslsstl tlskadyekh kvyacevthq		200

glsspvtksf nrgec								215

The position of cysteine (C) residues that form disulphide bridges and
asparagine residues that are N-glycosylated are highlighted in bold
(red).  

Molecular formula	not indicated (by applicant) 

Description

% hB



G

'

''

*

	



!

"

?

(

,

-

7

8

B

C

F

G

Q

R

\

]

g

4g

h

k

l

r

s

}

~

?

'

?

?

``

''

*

 

*

,

@

B

V

Z

?

b

v

x

?

?

?

r

yo

?

O

T

SH

'

o

r

b

'

hCHe

?42 and A?40) human monoclonal antibody; gamma1 heavy chain (Homo
sapiens VH-IGHG1) (229-215')-disulfide with kappa light chain (Homo
sapiens V-KAPPA-IGKC); (235-235'':238-238'')-bisdisulfide dimer.

	

WHO 

International Nonproprietary Names Programme	

02/05/2007

		

